J. Yamakoshi et al., Isoflavone aglycone-rich extract without soy protein attenuates atherosclerosis development in cholesterol-fed rabbits, J NUTR, 130(8), 2000, pp. 1887-1893
The antiatherogenic effect of soy protein with intact isoflavones is well e
stablished, but the effects of isoflavones without soy protein have not bee
n determined. We investigated the antiatherogenic effect of an isoflavone a
glycone-rich extract (containing 429.4 mg/g isoflavone aglycones) without s
oy protein from fermented soy in cholesterol-fed rabbits. We fed 12-wk-old
New Zealand white male rabbits diets containing 1 g/100 g cholesterol with
0, 0.33 or 1 g/100 g isoflavone aglycones for 8 wk. We also fed the rabbits
a diet containing 1 g/100 g cholesterol with 1.09 g/100 g soy saponin-rich
extract, a component other than isoflavone aglycones in the isoflavone agl
ycone-rich extract. Controls did not consume cholesterol, isoflavone aglyco
nes or saponins. The isoflavone aglycone- and saponin-rich extracts did not
affect the serum lipid profile of cholesterol-fed rabbits. The serum conce
ntration of daidzein in its conjugated form was significantly higher in the
high isoflavone group than in the low isoflavone group. The level of chole
steryl ester hydroperoxide (ChE-OOH) induced by CuSO4 in plasma in the high
isoflavone group was significantly less than that in the cholesterol group
, and the ChE-OOH levels of LDL in the low and high isoflavone groups were
significantly less than those in the cholesterol group. The ChE-OOH levels
in plasma and LDL in the saponin group did not differ from the cholesterol
group. In the aortic arch, the cholesterol concentration was significantly
lower in the high isoflavone group, and malondialdehyde concentration was s
ignificantly lower in the low and high isoflavone groups compared with the
cholesterol group; however these concentrations in the saponin group did no
t differ from those in the cholesterol group. The atherosclerotic lesion ar
ea of the aortic arch was significantly lower in the isoflavone groups (26.
3% lower in the low isoflavone group and 36.9% lower in the high isoflavone
group) than in the cholesterol group. The lesion areas were not different
in the soy saponin and cholesterol groups. Immunohistochemical analysis rev
ealed fewer oxidized LDL-positive macrophage-derived foam cells in atherosc
lerotic lesions in the aortic arch of isoflavone groups compared with that
of the cholesterol group. These results suggest that the antioxidative acti
on of isoflavones and their antioxidative metabolites inhibit the oxidation
of LDL, thereby exerting an antiatherosclerotic effect.